Thursday, January 19, 2006


Hepatitis C Information - Vertex Progresses with VX-950


Vertex Progresses with VX-950
Vertex is the racehorse to watch right now. They are progressing quicky on their preliminary good results. While it's not yet time to line up for their treatment, we believe theirs will be first to market of the new approaches...

MedMira Rapid Test
The start of the New Year was accompanied by the European Patent Office granting a patent for a rapid HCV test. Now that the technology is here, let's hope the test proves accurate, with high levels of selectivity and specificity....

Fatty Liver
Title: Fatty LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 8/29/2005

GlobeImmune Recruiting for Clinical Trial
While GlobeImmune's therapeutic vaccine for Hepatitis C is only in Phase Ib of clinical trials, their focus on immunity to the Hepatitis C virus is fascinating. GI-5005 is based on tarmogens being potent activators of antigen-specific immune responses against disease....

How to Choose a Doctor
Title: How to Choose a DoctorCategory: Doctor's ViewsCreated: 6/17/2005Last Editorial Review: 8/9/2005

Shorter Therapy Effective for Genotypes 2 and 3
Genotypes 2 and 3 are much more responsive to current interferon combination therapies. This report details studies that show a shorter course of treatment might be just as effective as longer courses. Researchers continue to refine treatment protocols for HCV...